Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like Struggling XBiotech Quietly Discloses Exec Resignation May 11, 2017 <b>Scientist.com</b> Launches Next-Generation Innovation Hub For Cutting-Edge Drug Research Tools And Technologies August 29, 2017 Calithera Biosciences Appoints To Board Of Directors September 21, 2017
<b>Scientist.com</b> Launches Next-Generation Innovation Hub For Cutting-Edge Drug Research Tools And Technologies August 29, 2017
